The exome data of NCI60 (Abaan et al., 2013) cell lines shows that each of the five breast cancer cell lines has between one to four missense or silencing TP53 mutations, and two to five missense or silencing mutations in BRCA2. Here, TP53 is linked to breast carcinoma.